River Road Asset Management LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 651.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 79,895 shares of the healthcare conglomerate’s stock after buying an additional 69,268 shares during the period. River Road Asset Management LLC’s holdings in UnitedHealth Group were worth $31,993,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the company. Fiera Capital Corp grew its stake in shares of UnitedHealth Group by 99.5% during the first quarter. Fiera Capital Corp now owns 2,137,018 shares of the healthcare conglomerate’s stock valued at $795,120,000 after acquiring an additional 1,065,868 shares in the last quarter. Capital International Investors lifted its position in shares of UnitedHealth Group by 5.8% during the first quarter. Capital International Investors now owns 18,899,258 shares of the healthcare conglomerate’s stock worth $7,032,097,000 after purchasing an additional 1,040,094 shares during the last quarter. Lazard Asset Management LLC lifted its position in shares of UnitedHealth Group by 185.4% during the first quarter. Lazard Asset Management LLC now owns 1,178,666 shares of the healthcare conglomerate’s stock worth $438,545,000 after purchasing an additional 765,729 shares during the last quarter. Ontario Teachers Pension Plan Board bought a new position in shares of UnitedHealth Group during the first quarter worth about $266,424,000. Finally, Franklin Resources Inc. lifted its position in shares of UnitedHealth Group by 15.3% during the first quarter. Franklin Resources Inc. now owns 3,944,677 shares of the healthcare conglomerate’s stock worth $1,467,697,000 after purchasing an additional 522,460 shares during the last quarter. Institutional investors and hedge funds own 86.21% of the company’s stock.
UNH has been the topic of a number of recent research reports. Bank of America raised their target price on shares of UnitedHealth Group from $450.00 to $522.00 and gave the stock a “buy” rating in a report on Tuesday, June 1st. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $418.00 to $421.00 and gave the company a “buy” rating in a report on Tuesday, July 13th. Seaport Global Securities started coverage on shares of UnitedHealth Group in a research report on Friday, July 9th. They issued a “buy” rating and a $450.00 price target on the stock. Wells Fargo & Company started coverage on shares of UnitedHealth Group in a research report on Monday, May 24th. They issued an “overweight” rating and a $478.00 price target on the stock. Finally, Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $430.00 to $462.00 and gave the stock an “outperform” rating in a research report on Friday, July 16th. Three equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $444.04.
Shares of UNH opened at $411.98 on Wednesday. The company has a market capitalization of $388.46 billion, a PE ratio of 27.25, a price-to-earnings-growth ratio of 1.62 and a beta of 0.77. UnitedHealth Group Incorporated has a one year low of $289.64 and a one year high of $431.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.77 and a quick ratio of 0.77. The company’s fifty day moving average price is $416.16 and its 200 day moving average price is $398.29.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 EPS for the quarter, topping the consensus estimate of $4.43 by $0.27. The firm had revenue of $71.32 billion for the quarter, compared to the consensus estimate of $69.51 billion. UnitedHealth Group had a net margin of 5.33% and a return on equity of 22.15%. The business’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter last year, the firm posted $7.12 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 18.74 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 21st. Investors of record on Monday, September 13th will be issued a $1.45 dividend. The ex-dividend date is Friday, September 10th. This represents a $5.80 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.36%.
UnitedHealth Group Company Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
See Also: Dividend Aristocrat Index
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.